A non-viral gene therapy for melanoma using α-hemolysin in combination with resiquimod
Chinese Chemical Letters · 2026-05 · 112938
DOI: 10.1016/j.cclet.2026.112938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-05. Verfasst von Ting Du und 11 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Chengdu Medical College, National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Chengdu Medical College
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Du, T., He, L., Wang, J., Pan, C., Xing, Y., Zhao, W., Yang, C., Dong, Y., Yang, S., Shen, M., Jia, X., & Gou, M. (2026). A non-viral gene therapy for melanoma using α-hemolysin in combination with resiquimod. Chinese Chemical Letters, 112938. https://doi.org/10.1016/j.cclet.2026.112938
Vancouver
Du T, He L, Wang J, Pan C, Xing Y, Zhao W, et al. A non-viral gene therapy for melanoma using α-hemolysin in combination with resiquimod. Chinese Chemical Letters. 2026:112938. doi:10.1016/j.cclet.2026.112938
BibTeX
@article{Du2026,
author = {Du, Ting and He, Liming and Wang, Jie and Pan, Chunyan and Xing, Yunkun and Zhao, Wei and Yang, Chunli and Dong, Yingchu and Yang, Shuai and Shen, Min and Jia, Xu and Gou, Maling},
title = {A non-viral gene therapy for melanoma using α-hemolysin in combination with resiquimod},
journal = {Chinese Chemical Letters},
year = {2026},
pages = {112938},
doi = {10.1016/j.cclet.2026.112938}
}
EUVIMED